Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL)
Journal of Gynecologic Oncology · 2025
DOI: 10.3802/jgo.2025.36.e13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Paul Buderath und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department for Gynecology and Obstetrics, University Hospital Essen, Essen, Germany. paul.buderath@uk-essen.de. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Lymph Node Excision, Robotic Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: Cancer-field surgery by peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL) for the treatment of endometrial cancer (EC) aims at optimal locoregional tumor control without the need for adjuvant radiotherapy. In a previous publication we could demonstrate the feasibility of the method and presented encouraging first oncologic data. METHODS: Following up our 2021 publication, we present data on the treatment of EC by PMMR+TCL in much larger cohort and with longer follow-up. RESULTS: One hundred and thirty-five patients with EC International Federation of Gynecology and Obstetrics (FIGO) I-IV (75.6% FIGO I) underwent cancer field surgery via PMMR+TCL for EC in the years 2016-2023. Mean follow-up in our cohort was 27.5 months (0, 83; 19.7). The procedure was feasible and safe with favorable intra-and postoperative complication rates. Even though 50.4% of patients had an indication for postoperative radiotherapy following national and international guidelines, the rate of postoperative irradiation administered was 10.4%. The overall recurrence rate was 8.1% and we observed 2 (1.5%) isolated locoregional recurrences. CONCLUSION: Our results confirm the feasibility and safety of PMMR+TCL in EC patients. Oncologic data are very encouraging and hint at a superior locoregional control without adjuvant irradiation. Larger studies with longer follow-up will be needed to confirm these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for Gynecology and Obstetrics, University Hospital Essen, Essen, Germany. paul.buderath@uk-essen.de.
- Department for Gynecology and Obstetrics, University Hospital Essen, Essen, Germany.
ORCID-Profile: Paul Buderath, Tra My Dang, Rainer Kimmig
Zitieren
APA
Buderath, P., Dang, T. M., & Kimmig, R. (2025). Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL). Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e13
Vancouver
Buderath P, Dang TM, Kimmig R. Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL). Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e13
BibTeX
@article{Buderath2025,
author = {Buderath, Paul and Dang, Tra My and Kimmig, Rainer},
title = {Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL)},
journal = {Journal of Gynecologic Oncology},
year = {2025},
doi = {10.3802/jgo.2025.36.e13}
}
EUVIMED